Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin
PHASE2CompletedINTERVENTIONAL
Enrollment
46
Participants
Timeline
Start Date
October 31, 2004
Primary Completion Date
May 31, 2006
Study Completion Date
May 31, 2006
Conditions
Ovarian Carcinoma
Interventions
DRUG
Paclitaxel
DRUG
Carboplatin
All Listed Sponsors
collaborator
Dana-Farber Cancer Institute
OTHER
collaborator
Brigham and Women's Hospital
OTHER
lead
Massachusetts General Hospital
OTHER
NCT00181701 - Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin | Biotech Hunter | Biotech Hunter